SciCombinator

Discover the most talked about and latest scientific content & concepts.

JY Choe, N Prodanovic, J Niebrzydowski, I Staykov, E Dokoupilova, A Baranauskaite, R Yatsyshyn, M Mekic, W Porawska, H Ciferska, K Jedrychowicz-Rosiak, A Zielinska, J Choi, YH Rho and JS Smolen
Abstract
To compare the efficacy, safety, immunogenicity and pharmacokinetics (PK) of SB2 to the infliximab reference product (INF) in patients with moderate to severe rheumatoid arthritis (RA) despite methotrexate therapy.
Tweets*
3
Facebook likes*
0
Reddit*
0
News coverage*
50
Blogs*
0
SC clicks
0
Concepts
Rheumatology, Psoriasis, Crohn's disease, Methotrexate, Infliximab, Ankylosing spondylitis, Psoriatic arthritis, Rheumatoid arthritis
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com